|
Exhibit 10.02
NOTICE: CONFIDENTIAL TREATMENT HAS BEEN
REQUESTED FOR
PORTIONS OF THIS DOCUMENT AS INDICATED HEREIN
LICENSE AGREEMENT
This License Agreement
("Agreement") is made and entered into as of the 28th day of
October, 1992, by and between Martek Biosciences Corporation, a
Delaware corporation ("Licensor"), and Mead Johnson & Company,
a Delaware corporation ("Licensee").
WITNESSETH:
WHEREAS, Licensor has developed
certain technology (the "Technology") relating to the production by
microbial fermentation of Omega-3 and Omega-6 long-chain
polyunsaturated fatty acid-containing triglycerides for possible
incorporation into infant formula; and
WHEREAS, Licensee is in the
business of developing, manufacturing and marketing infant
nutritional products; and
WHEREAS, Licensee desires to
obtain a non-exclusive license from Licensor for the Technology and
Licensor is willing to grant such license subject to the conditions
and pursuant to the terms set forth in this Agreement.
NOW, THEREFORE, in consideration
of the premises and of the mutual covenants of the parties hereto,
each party hereby agrees with the other as follows:
ARTICLE I
DEFINITIONS
Section 1.1. "
Affiliate " shall mean any person, corporation, firm,
partnership or other entity which directly or indirectly owns
Licensee, is owned by Licensee or is owned by a party which owns
Licensee to the extent of at least 50% of the equity having the
power to vote on or direct the affairs of the entity.
Section 1.2. For purposes of
Section 1.3 of this Agreement, " ARASCO " shall mean a
Martek Product containing no less than 15% arachidonic acid by
weight of fatty acids.
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 1 -
Section 1.3.
[ * ]
Section 1.4.
" Commercially Reasonable Volumes " shall mean a minimum of
1500 Kg. of ARASCO per year and 500 Kg. of DHASCO per year.
Section 1.5.
For purposes of Section 1.3 of this Agreement, " DHASCO
" shall mean a Martek Product containing no less than 30%
docosahexaenoic acid by weight of fatty acids.
Section 1.6.
" Infant Formula Product " shall mean an enteral product
formulated for the nutritional support of premature infants and/or
a breast milk substitute formulated industrially in accordance with
applicable Codex Alimentarius and United States Food and Drug
Administration standards to satisfy the total normal nutritional
requirements of infants up to between four and six months of age
and adapted to their physiological characteristics and fed in
addition to other foods to infants up to approximately one year of
age.
Section 1.7.
" Licensed Patents " shall mean the patent applications
attached hereto as Exhibit III and all patents and patent
applications throughout the world which cover the Technology,
including all patents and patent applications covering inventions,
improvements or modifications conceived or developed by Licensor
during the term of this Agreement and included in the
Technology.
Section 1.8.
" Martek Product " shall mean triglycerides containing
Omega-3 and/or. Omega-6 long-chain polyunsaturated fatty acids
produced by microbial fermentation using technology which is
proprietary to Licensor.
Section 1.9.
" Mead Johnson Product " shall mean a product (i) which
is an Infant Formula Product, (ii) which is in a form for
utilization by consumers, (iii) which is developed by Licensee
or its Affiliates, (iv) which bears Licensee’s label or
the label of an Affiliate or label licensed by Licensee or an
Affiliate, and (v) into which the Martek Product is
incorporated.
Section 1.10.
" Technology " shall mean the organisms, microorganisms,
specifications, biological materials, designs, formulae, processes,
standards, data, trade secrets, knowhow, copyrights and technology
relating to the development and production of the Martek Product
and proprietary to Licensor and any modifications, improvements and
enhancements to any of the foregoing made by Licensor, which, in
Licensor’s opinion, is or are necessary in the production and
development of the Martek Product.
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 2 -
Section 1.11.
" Territory " [ * ]
Section 1.12.
" Third Party " shall mean any party other than Licensor,
Licensee and Affiliates.
ARTICLE II
GRANT OF LICENSE AND OTHER RIGHTS
Section 2.1.
License .
(i) Licensor
hereby grants to Licensee for the term of this Agreement and
subject to the conditions of this Agreement, a non-exclusive,
non-transferable right and license throughout the Territory,
directly or through an Affiliate, under Licensed Patents and the
Technology, (A) to produce the Mead Johnson Product,
(B) to use and make the Martek Product for purposes of making
and having made the Mead Johnson Product and (C) to use,
market and distribute directly or indirectly the Mead Johnson
Product.
(ii) Licensor
further grants to Licensee the option to add the territory of [
* ] to the license granted under Section 2.1.(i) so that
the Territory as defined herein will include all countries
throughout the world, such option to be exercisable at any time
during the term of this Agreement upon payment of an additional fee
as specified in Section 4.1(i) of this Agreement.
Section 2.2.
Licenses to Third Parties
(i)
Licenses to Third Parties Generally . Licensor shall be
entitled to grant any license to any Third Party relating to the
Technology, the Martek Product or the Licensed Patents upon any
terms whatsoever; provided, however, that Licensor shall not grant
any license to any Third Party for the incorporation of the Martek
Product into, or for the use of the Technology for the production
of, an Infant Formula Product with payment terms which are more
favorable to such Third Party than the payment terms provided in
this Agreement with respect to the Licensee, without the prior
written consent of Licensee or unless such more favorable payment
terms prospectively are extended to Licensee. Notwithstanding the
preceding sentence, Licensor shall be entitled to charge lesser
lump sum payments to a Third Party licensee (similar to those
provided in subsections 4.1(i) and (ii) of this Agreement)
without the prior consent of Licensee and without being obligated
prospectively to extend such a payment term to Licensee, if the
license to such a Third Party is territorially restricted and if
the amount of the reduction in the lump sum charged
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 3 -
reasonably is related to the reduced marketing opportunities
available to such Third Party licensee due to the territorial
restrictions applicable to use of the Technology and the Martek
Product.
(ii)
Licenses to Third Party Suppliers . Licensor shall be
obligated to license the Technology, the Licensed Patents and the
Martek Product to Third Parties as follows:
(A) Licensor
shall use reasonable efforts further to license the Technology or
the Licensed Patents or otherwise to produce the Martek Product,
itself or through a Third Party whether or not pursuant to another
licensing arrangement, for the purpose of creating a sufficient
supply of the Martek Product to satisfy Licensee’s and its
Affiliates’ requirements with respect to their marketing and
sale of the Mead Johnson Product; provided, however, that such
requirements and any increases or decreases thereof, shall be
communicated in writing by Licensee to Licensor not less than nine
(9) months prior to Licensor’s obligation to satisfy
such requirements or increases or decreases thereof.
(B) If
Licensor licenses the Martek Product, the Licensed Patents and the
Technology to a Third Party pursuant to subsection (i) of this
Section 2.2, Licensor shall permit Licensee to negotiate the
terms of the purchase and supply arrangements between the Licensee
and such Third Party directly with such Third Party; provided,
however, that such direct negotiations or arrangements shall not
affect Licensor’s rights to royalties or other fees from
Licensee or such Third Party.
(C) If
the Third Parties to whom the Martek Product and the Technology are
licensed and Martek in the aggregate are unable to satisfy
Licensee’s and its Affiliates’ requirements for the
Martek Product (as established and communicated pursuant to
subsection (ii)(A) of this Section 2.2), Licensor shall
appoint one or more additional licensed suppliers who are
reasonably acceptable to Licensee and who can satisfy the excess
demands of Licensee and its Affiliates.
(D) Licensor
and Licensee acknowledge and agree that, at the time of the
execution of this Agreement, the production cost of the Martek
Product in gross quantities, the fair market value thereof and the
commercial volumes thereof necessary to meet Licensee’s
demands are not ascertainable, and Licensor and Licensee covenant
and agree that, prior to the first sale of a Mead Johnson Product,
Licensor and Licensee shall negotiate in good faith and agree upon
reasonable terms relating to the consideration to be payable by
Licensee or its
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 4 -
Affiliates to Licensor or Third Parties for amounts of the
Martek Product produced by or on behalf of Licensor and delivered
to Licensee or its Affiliates and upon commercially reasonable
volumes of Martek Product required by Licensee.
(iii)
Transfer of Martek Product . Nothing in this
Section 2.2 or in this Agreement shall be construed to permit
Licensee or its Affiliates to sub-license the Martek Product or the
Technology or otherwise unilaterally to transfer to any Third Party
the Martek Product or the Technology except as the same are
incorporated into the Mead Johnson Product.
Section 2.3.
Sublicensinq . The grants to Licensee under this
Article II shall not include the right to grant
sublicenses.
Section 2.4.
Trademarks . In addition to the license granted hereunder
relating to the Martek Product and the Technology, Licensor hereby
grants to Licensee the non-exclusive, non-transferable right and
license to use throughout the Territory the Trademark solely on,
and in connection with the manufacture and sale of, the Mead
Johnson Product, subject to the following terms and conditions:
(i) Licensee
shall not use the Trademark as or part of its corporate or business
name or the name of any business entity which is controlled by it,
whether an Affiliate or otherwise.
(ii) Licensee
and its Affiliates shall have no right to sublicense any of the
rights in the Trademark conveyed hereunder.
(iii) Licensee
and its Affiliates shall not affix or use the Trademark on any
product other than the Mead Johnson Product.
(iv) Licensee
recognizes and acknowledges Licensor’s ownership of the
Trademark and Licensor’s intent to protect the Trademark in
such foreign countries as Licensor, in its sole discretion, deems
appropriate. Licensee covenants and agrees that it and its
Affiliates shall not challenge, or cause a Third Party to
challenge, Licensor’s right, title or interest in and to the
Trademark anywhere in the world. All use by Licensee or its
Affiliates of the Trademark anywhere in the world shall inure to
the benefit of Licensor, and Licensee and its Affiliates shall make
no use or apply for any registration thereof except as permitted by
this Agreement. Nothing in this Agreement shall be construed so as
to require Licensor to take any actions or measures to protect or
secure any rights in or obtain or apply for registration of the
Trademark.
(v) Licensee
covenants that, upon notification from
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 5 -
Licensor that Licensor has obtained a U.S. Federal Registration
on the Trademark, Licensee will use the trademark registration
symbol® each time it or its Affiliates uses the Trademark on
the Mead Johnson Product or on the labels, labeling or packaging
thereof and on all material originating with Licensee or its
Affiliates and used to promote the sale of Mead Johnson Products,
and the following legend prominently shall appear at least once in
each such Mead Johnson Product or material: "Formulaid® is a
registered trademark of Martek Biosciences Corporation." Until such
time as Licensor obtains a U.S. Federal Registration on the
Trademark, Licensee shall substitute the symbol " TM " in place of the symbol® as
specified herein. Licensee further agrees that it will comply with
the marking and registered user requirements of all foreign
countries in which the Trademark is used, including, but not
limited to, requirements relating to the execution of any
documentation needed in order to effectuate the purpose of this
provision.
(vi) Licensee
covenants that Mead Johnson Products manufactured for and by it and
sold by it shall be of a high standard and quality so as to reflect
favorably upon the business of both Licensor and Licensee and the
goodwill associated therewith. To effectuate the foregoing:
(A) Prior
to the time that Licensee or its Affiliates shall sell or offer for
sale, in the regular course of business, any Mead Johnson Product
bearing the Trademark, Licensee shall submit to Licensor, for its
approval, samples of the Mead Johnson Product as well as samples of
all materials used to sell or to promote the sale of Mead Johnson
Products, including, but not limited to, labels, labeling,
packaging materials, advertising and other promotional materials.
Thereafter, Licensee and its Affiliates shall not make any change
to the Mead Johnson Product or to the way in which the Trademark is
used or depicted in connection with the Mead Johnson Product or
make any change in such materials used to sell or promote the sale
of the same without first submitting such proposed change to
Licensor and obtaining its approval.
(B) Licensor
shall have the right, at all times and upon reasonable advance
notice to Licensee, to request and receive without charge at
reasonable intervals throughout the term of this Agreement, a
reasonable number of samples of Mead Johnson Products and other
materials that depict the Trademark, in order that Licensor may
satisfy itself that such Mead Johnson Products and materials which
depict the Trademark conform to the samples thereof approved by
Licensor.
(C) No
approval required of Licensor under this
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 6 -
subsection (vi) shall be unreasonably withheld or delayed,
and any sample of a Mead Johnson Product bearing the Trademark or
materials used to sell or promote the sale of Mead Johnson Products
bearing the Trademark which have not been disapproved within
fifteen business days after receipt thereof shall be deemed to have
been approved.
(D) Licensee
shall advise Licensor of any infringement of the Trademark of which
it or its Affiliates becomes aware, but Licensee and its Affiliates
shall not bring any action with respect to any such infringement
without Licensor’s prior written consent. Licensee and its
Affiliates shall cooperate with Licensor, at Licensor’s
request, with respect to any of Licensor’s efforts to protect
its interests in the Trademark. Nothing in this Agreement shall be
construed so as to require Licensor to take any actions or measures
with respect to any alleged, suspected or known infringement of the
Trademark.
(E) Licensee
shall notify Licensor in writing prior to any material alterations
to the formula of the Mead Johnson Product bearing the
Trademark.
(vii) Nothing
in this Section 2.4 or in this Agreement shall be construed to
require Licensee or its Affiliates to use the Trademark on the Mead
Johnson Product or on the labels, labeling or packaging thereof or
on materials used to promote the sale of the Mead Johnson
Product.
Section 2.5.
Services . Licensor shall make its officers and other
employees available at reasonable times to provide technical and
other consultation services relating to (i) the delivery of
the Technology as contemplated under this Agreement and
(ii) instructions pertaining to the production of the Martek
Product at commercial volumes and costs, but only to the extent
that such services are commercially reasonable. This obligation to
perform services shall terminate on the first to occur of
(i) the termination of this Agreement, (ii) the fifth
anniversary date of this Agreement, (iii) the second
anniversary of the date on which the Mead Johnson Product is first
commercially introduced anywhere in the world and (iv) the
performance by Licensor’s employees of
[ * ] hours of such services.
Section 2.6.
Other Patents . Licensor shall not assert against Licensee
or its Affiliates any patent other than the Licensed Patents now or
later owned or controlled by Licensor which prevents Licensee or
its Affiliates from exploiting the Technology or the Martek
Product.
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 7 -
Section 2.7.
Licensee’s Property . Nothing in this Article II
or any other provision of this Agreement shall be construed to
prevent Licensee or its Affiliates from exploiting any technology
which an Affiliate independently develops and which does not
infringe upon any Licensed Patents, whether or not such technology
is similar to the Technology or to the Martek Product; provided,
however, that (i) no technology shall be considered hereunder
to be independently developed by an Affiliate unless such Affiliate
develops such technology under circumstances where no individual
associated with the development of such technology has been exposed
to confidential information delivered to Licensee or its Affiliates
pursuant to Article XII hereof or has otherwise been exposed
directly or indirectly to the Technology or the Martek Product;
(ii) this Section shall not be construed to permit Licensee or
its Affiliates to exploit the Technology or the Martek Product, to
market the Mead Johnson Product or to disclose information which is
confidential under Article XII hereof except as otherwise
expressly permitted under this Agreement; (iii) in the case of
the exploitation by Licensee or its Affiliates of any technology or
the disclosure of any information which is or are challenged by
Licensor in a court of competent jurisdiction as constituting a
breach of this Agreement or an infringement of Licensor’s
proprietary rights in the Technology or the Martek Product,
Licensee or its Affiliates, as applicable, shall bear the burden of
proving that such technology was independently developed by an
Affiliate; and (iv) nothing in this Section shall be construed
to prohibit Licensor or Licensee from enforcing a valid patent
granted to it in any jurisdiction against the Licensee, Licensor,
its Affiliates or any Third Person.
ARTICLE III
TERM AND TERMINATION
Section 3.1.
Term . This Agreement shall commence on the date of this
Agreement and, unless earlier terminated pursuant to this
Article III, shall expire, as to each country in which the
Mead Johnson Product is sold or otherwise distributed for consumer
use, on the date which is twenty five (25) years after the
first commercial introduction of the Mead Johnson Product in such
country. Upon expiration, Licensee shall have a fully paid, royalty
free license to continue in perpetuity to utilize the Martek
Product and the Technology as provided for in Section 2.1.
Section 3.2.
Material Breach; Opportunity to Cure . Either party to this
Agreement may immediately terminate this Agreement by written
notice and without judicial intervention if the other party shall
materially fail to comply with or shall materially breach any of
its obligations and covenants hereunder and shall not
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 8 -
remedy and make good such breach or failure, or have undertaken
to cure the same, within thirty (30) days from the receipt of
a written notice of failure of compliance or breach.
Section 3.3.
Termination in case of Infringement . Licensor or Licensee
shall have the right to terminate this Agreement with respect to
the manufacture, use or sale of the Technology or the Martek
Product in a particular jurisdiction within the Territory if a
court of competent jurisdiction therein determines by final order
that the Technology or the Martek Product, infringes upon the
patent of any Third Party; provided, however, that Licensor and
Licensee hereby covenant and agree that, prior to any such
termination, Licensor and Licensee shall engage in reasonable, good
faith efforts to develop, and shall cooperate with the other in
developing, a lawful method of using, selling or manufacturing, as
applicable, the Mead Johnson Product in the applicable
jurisdiction, including, but not limited to, commercially
reasonable efforts to procure a license from such Third Party or to
alter the design or offending composition of the Martek Product,
the Technology or the Mead Johnson Product, as applicable, so as to
eliminate the infringement. Any costs incurred by Licensor for its
procurement of a license from such a Third Party shall be the
responsibility of Licensor.
Section 3.4.
Post-Termination Rights . Effective upon the date of
termination of this Agreement pursuant to Section 3.2 or 3.3
hereof, Licensee and its Affiliates shall cease manufacturing the
Martek Product and the Mead Johnson Product provided, however,
that, to the extent lawful, Licensee and its Affiliates may
continue to distribute the Mead Johnson Products manufactured prior
to such date if Licensee continues to make payments under
Section 4.1 with respect to such Mead Johnson Products and
otherwise continues to comply with the terms and conditions of this
Agreement. Notwithstanding the preceding, upon the earlier to occur
of (i) the sale by Licensee and its Affiliates of all of their
inventory of Mead Johnson Products manufactured prior to the date
of the termination of this Agreement pursuant to Section 3.2
or 3.3 hereof and (ii) the date which is six months after the
date of the termination of this Agreement pursuant to
Section 3.2 or 3.3 hereof, Licensee and its Affiliates shall
cease all use of the Technology, sale of the Mead Johnson Product
and use of the Trademark and Licensee and its Affiliates shall have
no further rights under this Agreement.
Section 3.5.
Inability to Market the Mead Johnson Product
(i)
Refund . If Licensee and its Affiliates are prevented by
applicable law (e.g., inability to obtain legally required
regulatory approval or the existence of a Third Party patent
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 9 -
which, upon Licensee’s marketing of the Mead Johnson
Product, would subject Licensee to liability for infringement of
such Third Party patent, as concluded by a legal opinion issued by
an independent Third Party counsel mutually selected by Licensor
and Licensee) from marketing the Mead Johnson Product in the United
States despite its satisfaction of the refund - conditions set forth in
subsection (ii) of this Section by the third anniversary date
of this Agreement, or if Licensor is unable to refine the
development process for the Martek Product or supply the Martek
Product (directly or through Third Parties) in each case at
Commercially Reasonable Volumes and Commercially Reasonable Costs,
in accordance with the specifications set forth in Exhibit
IV of this Agreement and pursuant to representations and
warranties substantially similar in scope to those set forth in
Exhibit V of this Agreement by the third anniversary of
date of this Agreement, or if Licensor is incapable of producing
the Martek Product or having the Martek Product produced by a Third
Party in compliance with all applicable environmental laws,
regulations and permits by the third anniversary date of this
Agreement, then in any such case Licensee shall be entitled to
elect, within sixty days after such date, to terminate this
Agreement. If Licensee elects to terminate this Agreement pursuant
to the previous sentence, all fees paid by Licensee to Licensor by
such date pursuant to subsection (i) of Section 4.1 of
this Agreement (and not as of such date otherwise refunded to
Licensee), including any advances paid pursuant to the Letter of
Intent between Licensor and Licensee executed on or about
March 24, 1992 (the "Letter of Intent"), shall be refunded,
without interest, to the Licensee as follows:
(A) If
the stockholders of Licensor with a right of first refusal
respecting issuances of Licensor’s Common Stock, $.10 par
value per share (the "Common Stock"), fail to exercise such right
such that it is possible for the Licensor lawfully to issue
, shares of Common
Stock to Licensee, Licensor shall issue to Licensee Common Stock
against such refundable fees at a rate of one share of Common Stock
per: (1) in the event of a registered initial public offering
by Licensor of the Common Stock occurring subsequent to the
execution of this Agreement and prior to the third anniversary date
of this Agreement, the lesser of (x) $100 and (y) the last
sale price of the Common Stock on the national securities exchange
on which the Common Stock is traded, or, if the Common Stock is not
traded on a national securities exchange, the average of the bid
and asked prices for the Common Stock as reported by a recognized
quotation service, determined as of the date of Licensee’s
election to terminate this Agreement; or, (2) if a registered
initial public offering by Licensor of the Common Stock does not
occur prior to the third anniversary date of this Agreement, $100.
The $100 figure specified in clause (2) of this subparagraph
(A) shall be adjusted appropriately if, after the
date
*CONFIDENTIAL PORTION OMITTED AND FILED
SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION
- 10 -
of this Agreement, a change in the number of issued shares of
Common Stock occurs as the result of a subdivision or consolidation
of then outstanding shares of Common Stock or if then unissued
authorized stock (similarly adjusted for subdivision or
consolidation) is subsequently issued or for any other condition
which materially dilutes the Licensee’s potential ownership
share of the Licensor after the Agreement date.
(B) If
the stockholders of Licensor exercise their rights of first refusal
such that Licensor is unable lawfully to issue Common Stock to
Licensee in satisfaction of its refund obligations under this
Section 3.5, Licensor shall refund all refundable sums in
cash.
Licensee’s
right to terminate this Agreement and receive a refund of fees
under this Section 3.5 shall be Licensee’s exclusive remedy
for Licensor’s failure sufficiently to refine the development
process of the Martek Product or supply Martek Product (directly or
through Third Parties) and such right shall terminate at the
earliest to occur of the date which is sixty days after the third
anniversary of this Agreement, the date on which the Mead Johnson
Product is first commercially introduced anywhere in the world, or
the date on which Licensee materially breaches this Agreement.
(ii)
Refund Conditions . Licensee’s rights to a refund of
amounts paid pursuant to subsection (i) of Section 4.1 of
this Agreement shall be contingent upon Licensee’s use of
reasonable efforts to obtain, at its expense and as soon as
practicable, all necessary regulatory approvals with respect to the
use, mannufacture and sale of the Mead Johnson Product in the
United States, Licensee being responsible for performing all acts
necessary for obtaining such approvals, including, but not limited
to, the preparation of all necessary petitions or pre-market
approval applications with regulatory agencies and the performance
of all necessary tests and data preparation. Such refund is further
contingent upon Licensee promptly communicating to Licensor the
details of all regulatory approvals and efforts to obtain such
approvals in the United States and in any other jurisdiction in
which approval for the Mead Johnson Product is sought by Licensee
or its Affiliates, and Li
| 
